Logo image of IMBI

IMEDIA BRANDS INC (IMBI) Stock Fundamental Analysis

NASDAQ:IMBI - Nasdaq - US4524652066 - Common Stock - Currency: USD

0.11  -0.03 (-18.52%)

After market: 0.1026 -0.01 (-6.73%)

Fundamental Rating

1

Overall IMBI gets a fundamental rating of 1 out of 10. We evaluated IMBI against 31 industry peers in the Broadline Retail industry. IMBI has a bad profitability rating. Also its financial health evaluation is rather negative. IMBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IMBI had negative earnings in the past year.
IMBI had negative earnings in each of the past 5 years.
In multiple years IMBI reported negative operating cash flow during the last 5 years.
IMBI Yearly Net Income VS EBIT VS OCF VS FCFIMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

1.2 Ratios

IMBI has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMBI Yearly ROA, ROE, ROICIMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

IMBI's Gross Margin of 38.63% is in line compared to the rest of the industry. IMBI outperforms 57.14% of its industry peers.
In the last couple of years the Gross Margin of IMBI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for IMBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5Y1.27%
IMBI Yearly Profit, Operating, Gross MarginsIMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

More info and screens

0

2. Health

2.1 Basic Checks

IMBI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IMBI has been increased compared to 1 year ago.
The number of shares outstanding for IMBI has been increased compared to 5 years ago.
IMBI has a worse debt/assets ratio than last year.
IMBI Yearly Shares OutstandingIMBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
IMBI Yearly Total Debt VS Total AssetsIMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

IMBI has an Altman-Z score of -0.73. This is a bad value and indicates that IMBI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IMBI (-0.73) is worse than 77.14% of its industry peers.
IMBI has a Debt/Equity ratio of 9.96. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 9.96, IMBI is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 9.96
Debt/FCF N/A
Altman-Z -0.73
ROIC/WACCN/A
WACC5.69%
IMBI Yearly LT Debt VS Equity VS FCFIMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.10 indicates that IMBI should not have too much problems paying its short term obligations.
IMBI has a worse Current ratio (1.10) than 77.14% of its industry peers.
IMBI has a Quick Ratio of 1.10. This is a bad value and indicates that IMBI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IMBI (0.49) is worse than 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 0.49
IMBI Yearly Current Assets VS Current LiabilitesIMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

IMBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -191.86%.
IMBI shows a decrease in Revenue. In the last year, the revenue decreased by -1.19%.
The Revenue has been decreasing by -3.42% on average over the past years.
EPS 1Y (TTM)-191.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-256.52%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y2.76%
Revenue growth 5Y-3.42%
Sales Q2Q%-31.11%

3.2 Future

IMBI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.37% yearly.
The Revenue is expected to grow by 0.73% on average over the next years.
EPS Next Y47.17%
EPS Next 2Y31.29%
EPS Next 3Y23.73%
EPS Next 5Y17.37%
Revenue Next Year-16.47%
Revenue Next 2Y-4.63%
Revenue Next 3Y-2.59%
Revenue Next 5Y0.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMBI Yearly Revenue VS EstimatesIMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
IMBI Yearly EPS VS EstimatesIMBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IMBI. In the last year negative earnings were reported.
Also next year IMBI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMBI Price Earnings VS Forward Price EarningsIMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMBI Per share dataIMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

IMBI's earnings are expected to grow with 23.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.29%
EPS Next 3Y23.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IMBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

IMEDIA BRANDS INC

NASDAQ:IMBI (7/7/2023, 8:00:03 PM)

After market: 0.1026 -0.01 (-6.73%)

0.11

-0.03 (-18.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)07-05 2023-07-05/bmo
Earnings (Next)08-22 2023-08-22/bmo
Inst Owners0.02%
Inst Owner Change0%
Ins Owners16.22%
Ins Owner Change0%
Market Cap3.18M
Analysts82
Price Target1.53 (1290.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-320.36%
Min EPS beat(2)-518.4%
Max EPS beat(2)-122.32%
EPS beat(4)1
Avg EPS beat(4)-161.93%
Min EPS beat(4)-518.4%
Max EPS beat(4)5.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.73%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-12%
Revenue beat(4)0
Avg Revenue beat(4)-12.74%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)-1.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-70%
EPS NQ rev (1m)57.14%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-447.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-32.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.19
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.51
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS18.83
BVpS0.59
TBVpS-5.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.63%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.82%
GM growth 5Y1.27%
F-ScoreN/A
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 9.96
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 0.49
Altman-Z -0.73
F-ScoreN/A
WACC5.69%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-256.52%
EPS Next Y47.17%
EPS Next 2Y31.29%
EPS Next 3Y23.73%
EPS Next 5Y17.37%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y2.76%
Revenue growth 5Y-3.42%
Sales Q2Q%-31.11%
Revenue Next Year-16.47%
Revenue Next 2Y-4.63%
Revenue Next 3Y-2.59%
Revenue Next 5Y0.73%
EBIT growth 1Y-309.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.98%
EBIT Next 3Y57.85%
EBIT Next 5Y37.86%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A